Literature DB >> 21566749

Inflammatory breast cancer: the experience of Baylor University Medical Center at Dallas.

Justin M Goldfarb1, John E Pippen.   

Abstract

Entities:  

Year:  2011        PMID： 21566749      PMCID： PMC3069510          DOI： 10.1080/08998280.2011.11928688

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  10 in total

1.  Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.

Authors:  N T Ueno; A U Buzdar; S E Singletary; F C Ames; M D McNeese; F A Holmes; R L Theriault; E A Strom; B J Wasaff; L Asmar; D Frye; G N Hortobagyi
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

Review 2.  What progress have we made in managing inflammatory breast cancer?

Authors:  Shaheenah Dawood; Massimo Cristofanilli
Journal:  Oncology (Williston Park)       Date:  2007-05       Impact factor: 2.990

3.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Authors:  Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

Review 4.  Inflammatory breast cancer: a review.

Authors:  I A Jaiyesimi; A U Buzdar; G Hortobagyi
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

5.  International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

Authors:  S Dawood; S D Merajver; P Viens; P B Vermeulen; S M Swain; T A Buchholz; L Y Dirix; P H Levine; A Lucci; S Krishnamurthy; F M Robertson; W A Woodward; W T Yang; N T Ueno; M Cristofanilli
Journal:  Ann Oncol       Date:  2010-07-05       Impact factor: 32.976

6.  Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy.

Authors:  R Zucali; C Uslenghi; R Kenda; G Bonadonna
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

7.  High incidence of HER-2 positivity in inflammatory breast cancer.

Authors:  M Parton; M Dowsett; S Ashley; M Hills; F Lowe; I E Smith
Journal:  Breast       Date:  2004-04       Impact factor: 4.380

8.  Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?

Authors:  P Bonnier; C Charpin; C Lejeune; S Romain; N Tubiana; B Beedassy; P M Martin; H Serment; L Piana
Journal:  Int J Cancer       Date:  1995-08-09       Impact factor: 7.396

9.  Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

Authors:  A Paradiso; S Tommasi; M Brandi; F Marzullo; G Simone; V Lorusso; A Mangia; M De Lena
Journal:  Cancer       Date:  1989-11-01       Impact factor: 6.860
  10 in total
  4 in total

1.  Inflammatory breast carcinoma.

Authors:  Kelli Y Ha; Shannon B Glass; Louba Laurie
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

2.  Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization.

Authors:  Kevin P Williams; Jennifer L Allensworth; Shalonda M Ingram; Ginger R Smith; Amy J Aldrich; Jonathan Z Sexton; Gayathri R Devi
Journal:  Cancer Lett       Date:  2013-05-17       Impact factor: 8.679

Review 3.  Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.

Authors:  Riley J Morrow; Nima Etemadi; Belinda Yeo; Matthias Ernst
Journal:  Mediators Inflamm       Date:  2017-05-14       Impact factor: 4.711

4.  Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.

Authors:  Ryan A Denu; John M Hampton; Adam Currey; Roger T Anderson; Rosemary D Cress; Steven T Fleming; Joseph Lipscomb; Xiao-Cheng Wu; J Frank Wilson; Amy Trentham-Dietz
Journal:  J Cancer Epidemiol       Date:  2017-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.